One-time treatment generates new neurons, eliminates Parkinson's disease in mice - Paris Redox World Congress 2020 - October 8 - 9, 2020 - Virtual Congress

One-time treatment generates new neurons, eliminates Parkinson's disease in mice

235235 webLeft: mouse astrocytes (green) before reprogramming; Right: neurons (red) induced from mouse astrocytes after reprogramming with PTB antisense oligonucleotide treatment.
Credit: UC San Diego Health Sciences

Inhibiting a single gene converts many cell types directly into dopamine-producing neurons

Xiang-Dong Fu, PhD, has never been more excited about something in his entire career. He has long studied the basic biology of RNA, a genetic cousin of DNA, and the proteins that bind it. But a single discovery has launched Fu into a completely new field: neuroscience.

For decades, Fu and his team at University of California San Diego School of Medicine studied a protein called PTB, which is well known for binding RNA and influencing which genes are turned "on" or "off" in a cell. To study the role of a protein like PTB, scientists often manipulate cells to reduce the amount of that protein, and then watch to see what happens.

Several years ago, a postdoctoral researcher working in Fu's lab was taking that approach, using a technique called siRNA to silence the PTB gene in connective tissue cells known as fibroblasts. But it's a tedious process that needs to be performed over and over. He got tired of it and convinced Fu they should use a different technique to create a stable cell line that's permanently lacking PTB. At first, the postdoc complained about that too, because it made the cells grow so slowly.

But then he noticed something odd after a couple of weeks -- there were very few fibroblasts left. Almost the whole dish was instead filled with neurons.

In this serendipitous way, the team discovered that inhibiting or deleting just a single gene, the gene that encodes PTB, transforms several types of mouse cells directly into neurons.

More recently, Fu and Hao Qian, PhD, another postdoctoral researcher in his lab, took the finding a big step forward, applying it in what could one day be a new therapeutic approach for Parkinson's disease and other neurodegenerative diseases. Just a single treatment to inhibit PTB in mice converted native astrocytes, star-shaped support cells of the brain, into neurons that produce the neurotransmitter dopamine. As a result, the mice's Parkinson's disease symptoms disappeared.

The study is published June 24, 2020 in Nature.

"Researchers around the world have tried many ways to generate neurons in the lab, using stem cells and other means, so we can study them better, as well as to use them to replace lost neurons in neurodegenerative diseases," said Fu, who is a Distinguished Professor in the Department of Cellular and Molecular Medicine at UC San Diego School of Medicine. "The fact that we could produce so many neurons in such a relatively easy way came as a big surprise."

There are several different ways to mimic Parkinson's disease in mice. In this case, the researchers applied a dopamine look-a-like molecule to poison neurons that produce dopamine. As a result, the mice lose dopamine-producing neurons and develop symptoms similar to Parkinson's disease, such as movement deficiencies.

The treatment works like this: The researchers developed a noninfectious virus that carries an antisense oligonucleotide sequence -- an artificial piece of DNA designed to specifically bind the RNA coding for PTB, thus degrading it, preventing it from being translated into a functional protein and stimulating neuron development.

Antisense oligonucleotides, also known as designer DNA drugs, are a proven approach for neurodegenerative and neuromuscular diseases -- study co-author, Don Cleveland, PhD, pioneered the technology, and it now forms the basis for a Food and Drug Administration (FDA)-approved therapy for spinal muscular atrophy and several other therapies currently in clinical trials. Cleveland is chair of the Department of Cellular and Molecular Medicine at UC San Diego School of Medicine and member of the Ludwig Institute for Cancer Research, San Diego.

The researchers administered the PTB antisense oligonucleotide treatment directly to the mouse's midbrain, which is responsible for regulating motor control and reward behaviors, and the part of the brain that typically loses dopamine-producing neurons in Parkinson's disease. A control group of mice received mock treatment with an empty virus or an irrelevant antisense sequence.

In the treated mice, a small subset of astrocytes converted to neurons, increasing the number of neurons by approximately 30 percent. Dopamine levels were restored to a level comparable to that in normal mice. What's more, the neurons grew and sent their processes into other parts of brain. There was no change in the control mice.

By two different measures of limb movement and response, the treated mice returned to normal within three months after a single treatment, and remained completely free from symptoms of Parkinson's disease for the rest of their lives. In contrast, the control mice showed no improvement.

"I was stunned at what I saw," said study co-author William Mobley, MD, PhD, Distinguished Professor of Neurosciences at UC San Diego School of Medicine. "This whole new strategy for treating neurodegeneration gives hope that it may be possible to help even those with advanced disease."

What is it about PTB that makes this work? "This protein is present in a lot of cells," Fu said. "But as neurons begin to develop from their precursors, it naturally disappears. What we've found is that forcing PTB to go away is the only signal a cell needs to turn on the genes needed to produce a neuron."

Of course, mice aren't people, he cautioned. The model the team used doesn't perfectly recapitulate all essential features of Parkinson's disease. But the study provides a proof of concept, Fu said.

Next, the team plans to optimize their methods and test the approach in mouse models that mimic Parkinson's disease through genetic changes. They have also patented the PTB antisense oligonucleotide treatment in order to move forward toward testing in humans.

"It's my dream to see this through to clinical trials, to test this approach as a treatment for Parkinson's disease, but also many other diseases where neurons are lost, such as Alzheimer's and Huntington's diseases and stroke," Fu said. "And dreaming even bigger -- what if we could target PTB to correct defects in other parts of the brain, to treat things like inherited brain defects?

"I intend to spend the rest of my career answering these questions."

News Source: www.eurekalert.org

Article reference:

Qian, H., Kang, X., Hu, J. et al. Reversing a model of Parkinson’s disease with in situ converted nigral neurons. Nature 582, 550–556 (2020). https://doi.org/10.1038/s41586-020-2388-4

Redox in the Press & Media

Surplus antioxidants are pathogenic for hearts and skeletal muscle

Credit : CC0 Public Domain  Many heart diseases are linked to oxidative stress, an overabundance of reactive oxygen species. The body reacts to reduce oxidative stress—where the...

Read more

One-time treatment generates new neurons, eliminates Parkinson's disease in mice

Left: mouse astrocytes (green) before reprogramming; Right: neurons (red) induced from mouse astrocytes after reprogramming with PTB antisense oligonucleotide treatment.Credit: UC San Diego Health Sciences Inhibiting...

Read more

A New Blood Component Revealed

Functional extracellular mitochondria revealed in the blood circulation. ©Alain R. Thierry/Inserm   Does the blood we thought to know so well contain elements that had been undetectable...

Read more

Hydrogen sulfide: a target to modulate oxidative stress and neuroplasticity for the treatment of pathological anxiety

We remind you that during Paris Redox 2020, a specific session will be dedicated to Redox, H2S and Microbiota. We selected for you paper published by...

Read more

SOD1 deficiency alters gastrointestinal microbiota and metabolites in mice

Redox imbalance induces oxidative damage and causes age-related pathologies. Mice lacking the antioxidant enzyme SOD1 (Sod1-/-) exhibit various aging-like phenotypes throughout the body and are...

Read more

Hydrogen Sulfide: Recent Progressxion and Perspectives for the Treatment of Diabetic Nephropathy

Diabetic kidney disease develops in approximately 40% of diabetic patients and is a major cause of chronic kidney diseases (CKD) and end stage kidney disease...

Read more

New cause of cell aging discovered

    Cells illustration (stock image). Credit: © Anusorn / Adobe Stock   New research from the USC Viterbi School of Engineering could be key to our understanding of how...

Read more

Paris Redox 2019: A round table discussion dedicated to Reactive Species Interactome by Prof Marvin Edeas

Marvin Edeas, chairman of the Scientific Committee of Paris Redox 2019, Institut Cochin, Inserm U1016, University Paris Descartes, France will moderate a round table discussion...

Read more

Study Provides New Insights For Ways to Use Cell Metabolism to Treat Cancer

Researchers at the University of Cincinnati (UC) College of Medicine have discovered that cell metabolism plays an important role in the ability of cells to...

Read more

Scientists reverse Aging-associated skin wrinkles and hair loss in a mouse model

Wrinkled skin and hair loss are hallmarks of aging. What if they could be reversed? Keshav Singh, Ph.D., and colleagues have done just that, in a...

Read more

Beef jerky and other processed meats associated with manic episodes

An analysis of more than 1,000 people with and without psychiatric disorders has shown that nitrates—chemicals used to cure meats such as beef jerky, salami...

Read more

Non-antibiotic antimicrobial triclosan induces multiple antibiotic resistance through genetic mutation

Mutations led to resistance by up-regulating beta-lactamase and multi-drug efflux pump. Antibiotic resistance poses a major threat to public health. Overuse and misuse of antibiotics are...

Read more

Is There a Link Between Diabetes and Parkinson's Disease?

People with type 2 diabetes may have an increased risk of having a diagnosis of Parkinson's disease later in life, according to a large study...

Read more

Imaging Method Evaluates Cell Functional Changes and Wound Healing

Optical redox ratio maps of fibroblasts isolated from young and aged rats. Red regions correspond to high redox ratios, while blue regions correspond to low...

Read more

Can Vitamins and Supplements Help Patients with Mitochondrial Disease?

Defects in mitochondria, the tiny structures that power our cells by functioning as biological batteries, cause an array of complex, often life-threatening disorders that can...

Read more

'Natural insecticide' kills advanced prostate cancer cells: A Mitochondria issue

  Researchers reveal how a 'natural insecticide' can destroy advanced prostate cancer cells.   One of the hallmarks of advanced prostate cancer is a faulty PTEN tumor suppressor...

Read more

Cells stressed out? Make mitochondria longer

Scientists at The Scripps Research Institute (TSRI) have discovered a new pathway in cells that promotes mitochondrial function during times of stress, a response that...

Read more

Microcapsules Gain a New Power - Scavenging Reactive Oxygen Species

Stable, biocompatible microcapsules from the lab of Eugenia Kharlampieva have gained a new power — the ability to scavenge reactive oxygen species. This may aid microcapsule...

Read more

Non-invasive detection of oxidative-stress biomarkers in exhaled air – an overview

During Paris Redox Congress 2018, Dr Guillaume Suarez, Head of Environmental Engineering group at Institut universitaire romand de Santé au Travail in Lausanne, Switzerland will...

Read more

Lifespan and oxidative stress in Amish: What is the role of antioxidants?

In a study published in November 2017 by Prof. Douglas Vaughan, University of Chicago, it was shown that a rare genetic mutation that has boosted...

Read more

Redox biomarker could predict progression of epilepsy

Approximately 2.9 million people in the United States suffer from epilepsy, according to the CDC. For patients living with this diagnosis and their doctors it...

Read more

Safe utilisation of dietary sugars requires dynamic control of redox balance

Dietary sugars, such as glucose, are sensed intracellularly by a regulatory system, which includes transcription factor Mondo-Mlx and protein kinase SIK3. Together they...

Read more

The 19th edition of Paris Redox Congress was a successful event

The 19th International conference on Oxidative Stress Reduction, Redox Homeostasis and Antioxidants " Paris Redox 2017" took place at Université Pierre et Marie Curie (UPMC)...

Read more

Regional fat distribution in women: The relation to metabolic hormones, risk markers and total anti-oxidant status

Cardiovascular risk in postmenopausal women has been partly attributed to increased visceral fat accumulation. The team of Dr Saleh conducted a controlled study on healthy...

Read more
  • 1
  • 2
  • 3
Prev Next